
Musk’s Stock Sales; Pfizer’s Covid Pill; Slack and the Newest Normal
As the specter of omicron looms large over the festive season, governments around the world are desperately trying to deploy Covid-19 booster shots in order to bolster people’s protection against the more transmissible variant. Meanwhile, Pfizer is working on the first antiviral Covid-19 pill. CNBC’s Meg Tirrell broke down the final analysis of Pfizer’s Covid-19 pill that showed a near 90% efficacy in preventing hospitalizations and deaths in high-risk patients. Companies from Lyft to Ford have had to delay and reassess return-to-office plans in recent weeks. Morgan Stanley CEO James Gorman…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.